Start and Grow a Profitable Botox®, Aesthetic Medicine or Medical Weight Management Practice

Xeomin® Training for Physicians

Xeomin training

The number one most requested aesthetic procedure is for Botulinum Toxin (Botox®) injections.  Merz Aesthetics offers a competitor to Botox® – Xeomin®.  Xeomin® comes in 100 unit vials just like Botox® and behaves the same way as Botox®. For more information on Xeomin® for cosmetic patients, check out our information sheet.

The International Association for Physicians in Aesthetic Medicine (IAPAM) provides physicians (MD/DO’s), PAs, and NPs with comprehensive hands-on Xeomin® injection training led by board-certified cosmetic dermatologists.

The IAPAM’s offers the only Xeomin® injection training program course, where:

  • Injections are done in a CLEAN medical practice (per FDA), NOT a hotel room.
  • You will receive certification from the IAPAM, an internationally recognized medical association.
  • Designed by Physicians for Physicians
  • Training is lead by a board certified dermatologist (see our complete faculty)

Make more and work less by growing a profitable aesthetics practice. 

Learn the clinical and business skills you need to transform your work/life balance in just 4-days!

April 19-22, 2024 (only 5 spots left!)
May 31-June 3, 2024
September 6-9, 2024
in sunny Scottsdale, AZ

Learn to Start a Profitable Aesthetics Practice in Just 4-Days!

April 19-22 (only 5 spots left!)
May 31-June 3
September 6-9

in sunny Scottsdale, AZ

Only $4,195*

Earn 33.5 CMEs

*Members preferred price for 4-day accelerated program. Membership is only $295/yr and can be added during registration.

Xeomin® Information

Executive Summary

  • Xeomin is available in the US as a treatment of glabellar lines
  • The main difference between Xeomin and Botox or Dysport, is that Xeomin contains just one ingredient: botulinum toxin A.
  • Xeomin is a “naked injectable,” meaning that it does not contain any additives. A benefit of a pure-form injectable is that the human body is less likely to become resistant to it.
  • Xeomin is the only one of the three (Xeomin, Botox and Dysport) that does not need to be refrigerated before use.
  • The cost of Xeomin is roughly the same as for Botox.
  • Xeomin has a similar “onset” of action (3-4 days) as Botox.
  • Xeomin may be “mildly more convenient” than Botox or Dysport, as the “product’s lack of complex proteins will help prevent antibody formation, or resistance to neuromuscular treatment with botulinum type A toxin, in patients being treated for neuromuscular conditions.”

Xeomin has available outside the US since 2005, and was introduced in the US in 2010.  Xeomin was given the FDA approval in July 2011 for the treatment of cervical dystonia, blepharospasm, and glabellar lines, but an injuction halted the release. 

Now, after a 10 month injunction, Xeomin is again being launched in the US as a treatment of glabellar lines.  Xeomin®, by Merz Pharmaceuticals LLC, is a competitor to the well established Botox Cosmetic® and lesser used Dysport®.

Patients are less likely to become resistant to Xeomin because there are simply less ingredients in the solution. Some patients have developed antibodies to Botox and Dysport.

Instructions for Preparation, Dosage and Administration

Xeomin is supplied in vials containing 50 or 100 Units of incobotulinumtoxinA, 1 mg of human albumin, and 4.7 mg sucrose. Xeomin should be reconstituted with sterile, preservative-free 0.9% Sodium Chloride Injection, USP.  

Reconstituted XEOMIN solution should be administered within 24 hours after dilution.  During this time period, reconstituted XEOMIN should be stored in a refrigerator 2-8°C (36-46°F).

Xeomin does not need to be refrigerated prior to reconstitution and has a shelf life of 3 years.

Reconstitution instructions are provided for both vial volumes:

Volume of Preservative-free 0.9% Sodium Chloride Injection, USP

50 Unit Vial:  Resulting dose in   Units per 0.1 mL

100 Unit Vial:  Resulting does   in Units per 0.1 mL

0.25 mL

20 Units

0.5 mL

10 Units

20 Units

1 mL

5 Units

10 Units

1.25 mL

4 Units

8 Units

2 mL

2.5 Units

5 Units

2.5 mL

2 Units

4 Units

4 mL

1.25 Units

2.5 Units

5 mL

1 Unit

2 Units

8 mL

1.25 Units

Re-treatment with XEOMIN should be administered no more frequently than every three months.

A suitable sterile needle 30-33 gauge (0.3-0.2 mm diameter), 13 mm length should be used in the administration in the treatment of glabellar lines.

The median first onset of XEOMIN effect occurs within seven days after injection. The typical duration of effect of each treatment is 3-4 months, but effects can last up to 6 months.

Cost

The cost for Xeomin is reported to be slightly less, but roughly the same as the cost of Botox®.*

It is anticipated that the average retail cost to a patient in the US, for a Xeomin treatment, is between $100.00 – $600.00 every 3-4 months.  It is dependent on the areas treated.

The Most Comprehensive Botox® Training Program
Learn everything you need to transform your life to making more and working less by growing your own profitable aesthetics practice or medical spa!
April 19-22 (only 5 spots left!)

Scottsdale, Arizona 

Botox is a trademark of Allergan Inc.; Dysport is a trademark of Galderma; Xeomin is a trademark of Merz Aesthetics